药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Misoprostol
Belinostat
The risk or severity of adverse effects can be increased when Everolimus is combined with Belinostat.
Misoprostol
Pirfenidone
The risk or severity of adverse effects can be increased when Everolimus is combined with Pirfenidone.
Misoprostol
Brequinar
The risk or severity of adverse effects can be increased when Everolimus is combined with Brequinar.
Misoprostol
2-Methoxyethanol
The risk or severity of adverse effects can be increased when Everolimus is combined with 2-Methoxyethanol.
Misoprostol
Vorinostat
The risk or severity of adverse effects can be increased when Everolimus is combined with Vorinostat.
Misoprostol
Castanospermine
The risk or severity of adverse effects can be increased when Everolimus is combined with Castanospermine.
Misoprostol
Stepronin
The risk or severity of adverse effects can be increased when Stepronin is combined with Everolimus.
Misoprostol
Nelarabine
The risk or severity of adverse effects can be increased when Nelarabine is combined with Everolimus.
Misoprostol
Eculizumab
The risk or severity of adverse effects can be increased when Eculizumab is combined with Everolimus.
Misoprostol
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Everolimus.
Misoprostol
Capecitabine
The risk or severity of adverse effects can be increased when Capecitabine is combined with Everolimus.
Misoprostol
Flucytosine
The risk or severity of adverse effects can be increased when Flucytosine is combined with Everolimus.
Misoprostol
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Everolimus.
Misoprostol
Mycophenolic acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Everolimus.
Misoprostol
Hydroxyurea
The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Everolimus.
Misoprostol
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Everolimus.
Azacitidine
Satralizumab
The serum concentration of Ketazolam can be decreased when it is combined with Satralizumab.
Azacitidine
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Ketazolam is combined with Oliceridine.
Azacitidine
Abametapir
The serum concentration of Ketazolam can be increased when it is combined with Abametapir.
Azacitidine
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Ketazolam.